Posted 29 April 2010 - 04:46
Government to demand no frills cigarette packets
Australia is set to become the first country in the world to introduce plain packaging for cigarettes.
The World Health Organisation (WHO), in its Framework Convention on Tobacco Control, advises authorities to "consider adopting measures to restrict or prohibit the use of logos, colours, brand images or promotional information".
Tough government regulations on tobacco advertising have reduced smoking in Australia from 30.5 per cent of the population aged 14 and over in 1988 to 16.6 per cent in 2007.
The Government is aiming to cut smoking rates below 10 per cent by 2018.
At last, truth in cigarette advertising
The tobacco industry has long acknowledged the huge importance that packaging has within the marketing mix. In 1995, a tobacco industry executive summed it up perfectly, ". . . if you smoke, a cigarette pack is one of the few things you use regularly that makes a statement about you. A cigarette pack is the only thing you take out of your pocket 20 times a day and lay out for everyone to see. That's a lot different than buying your soap powder in generic packaging."
Plain packaging is nothing short of a triumph for health promotion and chronic disease prevention. In studies with young people, plain packs were perceived as dull and boring, cheap-looking and reduced the flair and appeal associated with smoking. Conversely, the industry has invested heavily in researching and designing packages that serve to increase the appeal of smoking. In the industry's own words, packs aimed at younger women should be "slick, sleek, flashy, glittery, shiny, silky, and bold". A brown box featuring a diseased lung can hardly be seen as fitting this glamorous description.
No doubt hardened smokers will scoff at the notion that plain packaging could possibly influence their decision to either quit or to keep smoking. But this is certainly not the case for younger, new smokers. Just as designer clothing, fashion accessories and fast cars serve as cues to style, status and character so too can a cigarette pack reinforce social identity. Under these new packaging laws cigarette packs will only serve to signify addiction, disease, and death. Finally, there will be some truth in cigarette advertising.
Share & Enjoy
Posted 29 April 2010 - 08:39
For $520 Million, AstraZeneca Will Settle Case Over Marketing of a Drug
AstraZeneca has completed a deal to pay $520 million to settle federal investigations into marketing practices for its blockbuster schizophrenia drug, Seroquel. The Justice Department plans a news conference on Wednesday to disclose details of the case, according to two people close to the negotiations who were not authorized to discuss it publicly.
AstraZeneca becomes the fourth pharmaceutical giant in the last three years to admit to federal charges of illegal marketing of antipsychotic drugs, a lucrative category of medications that have quickly risen to the top of United States sales charts. Aggressive sales and promotional practices have helped expand the use of powerful new antipsychotic drugs for children and the elderly.
The company will join a series of American pharmaceutical companies that have admitted to illegal marketing after federal investigations and whistle-blower filings and have signed agreements with the government to monitor and avoid such activity in the future.
In the largest such case, Pfizer paid $2.3 billion last September, including $1.3 billion in the biggest criminal fine of any type in United States history, for off-label marketing of the painkiller Bextra and other drugs. Bextra was withdrawn from the market in 2005. The Pfizer fine included $301 million for off-label marketing of its antipsychotic drug Geodon.
Eli Lilly paid $1.4 billion in January 2009 to settle investigations into illegal marketing of its antipsychotic drug Zyprexa. Lilly’s settlement included a $515 million criminal fine, which until the Pfizer case was the largest such fine ever imposed on a corporation.
In 2007, Bristol-Myers Squibb and a subsidiary paid $515 million to settle federal and state investigations into marketing of its antipsychotic drug Abilify.
According to company e-mail unsealed in civil lawsuits, AstraZeneca “buried” — a manager’s term — a 1997 study that showed Seroquel users gained 11 pounds a year, while publicizing a study that claimed users lost weight. Company e-mail messages also refer to doing a “great smoke-and-mirrors job” on unfavorable studies.
Share & Enjoy
Posted 26 July 2010 - 20:16
evo nadjoh neku knjigu u knjiyari koju je napisao kanadski novinar...i pric bas o tome kako je marketing unistio stosta u svetu i ljudima.
moguce je da cete to sve nazvati gluposcu, ali cisto da se zna da milenko ima publikovanog sumisljenika sa ove strane okeana.
kako se zove knjiga i ko je autor?
Posted 03 August 2010 - 22:10